Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

ODYSSEY OUTCOMES Committees and Investigators

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Fingerprint Dive into the research topics of 'Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences